Phase 2 Trial Of Sacituzumab Tirumotecan For Treatment Of Refractory Metastatic Or Unresectable Squamous Cell Carcinoma Of The Anus/Rectum

NCT07511023 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Phase 2
Sacituzumab Tirumotecan
Refractory Metastatic
Unresectable Squamous
Cell Carcinoma of the Anus/ Rectum

Interventions

DRUG: Sacituzumab Tirumotecan

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]